McKesson (NYSE:MCK) will report earnings after markets close on Tuesday, May 7th. McKesson Corporation distributes pharmaceuticals, medical-surgical supplies, and and health and beauty care products throughout North America. The Company also develops, implements, and supports software that facilitates the integration of data throughout the health enterprise. In addition, McKesson offers analytic, care management, and patient solutions for payers.
Here is your Cheat Sheet to Mckesson Earnings:
Earnings Expectations: Analysts expect earnings of $2.31 per share on revenues of $32.01 billion. Currently, the company’s P/E ratio stands at 16.03.
Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $1.69 to a profit $1.66. For the current year, the average estimate is a profit of $7.21, which is worse than the estimate ninety days ago.
Here’s how Mckesson has been performing on an annual basis:
|Revenue ($) in millions||101,700||106,630||108,700||112,080||122,730|
|Diluted EPS ($)||3.32||2.95||4.62||4.57||5.59|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Dec. 31, 2011||Mar. 31, 2012||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012|
|Revenue ($) in millions||30,840||31,700||30,800||29,850||31,190|
|Diluted EPS ($)||1.20||2.101||1.58||1.67||1.24|
Mckesson has beat analyst estimates 3 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)